| Date | Speaker/Organization | Title/Topic |
| Jan 23 | Richard H. DeMarle '73 CE
Interim CEO, Ultraguard Corporation
| Superb Strategies Deserve Exceptional Execution...Driving Organization Performance |
| Jan 30 |
| Cancelled
|
| Feb 6 | Ugochi C. Nwachukwu '06 ChE
Fabric & Home Care R&D, Procter & Gamble
| Real world Applications of Engineering that address important industry challenges |
| Feb 13 | Carl J. Accettura '75 ME
Founder and Managing Director, Global Pharma Consulting
| Pharmaceutical New Product Commercialization |
| Feb 20 | Ray Coulombe '71 EE
Manager, Industry Consulting for the Physical Security Business Unit (PSBU) of Cisco's Emerging Technologies Group
| What's Different about Product Development in an Early Stage Company? |
Feb 27
|
| Cancelled |
| Mar 5 |
| Cancelled |
Mar 12
| Elissa P. Sterry '79 ORIE, MS '80
Global Vice President, Intermediates, ExxonMobil Chemical Company
| Tomorrow's Energy - Challenges for Engineers |
| Mar 19 | Spring Break | No Seminar
|
| Mar 26 | Justin R. Rattner '70 EE, MEng '72 EE
Executive Vice President and Chief Technology Officer
Intel Corporation | Digital Revolution - How it has Impacted Quality of Life, Opportunities it Creates, and How Stuends can Become Revolutionaries
|
| Apr 2 | Donald M. Aubrecht '06 EP
Graduate Researcher, Harvard University, School of Engineering & Applied Sciences
| Innovation: What To Do When the Problem Sets End |
| Apr 9 | Andrew L. P. Kellner '87 EP, MEng '88 EE, MBA '89
Managing Director - Barclays Capital
| TBD |
Apr 16
| Donald E. Morel Jr. MS '83 MSE, PhD '84
Chairman and CEO, West Pharmaceutical Services
| Managing through a Corporate Crisis: An Engineer's Perspective |
| Apr 23 | Craig Wheeler '82 ChE, MS '84
President & CEO, Momenta Pharmaceuticals
| Follow on Biologics: From Cambridge to K Street |
Apr 30
| Brian G. Kushner '78 EP, MS '80 AP, PhD '84
Principal & Partner, CXO LLC
| Engineering the Turnaround: What Happens When Things Go Terribly Wrong and Roles/Opportunities for Engineers in These Situations
|
